Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
John Hall Alimera Sciences Ltd., Aldershot, Hampshire, UK I read “Dexamethasone intravitreal implant in the treatment of diabetic macular edema” published July 2015 by Dugel et al.1This article is very interesting in terms of providing an
Hall J
doaj
Clinical effectiveness of the 0.18 mg fluocinolone acetonide intravitreal implant for non-infectious uveitis-associated macular edema: a real-world study. [PDF]
Chen C +7 more
europepmc +1 more source
Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN® clinical evidence study in Portugal. [PDF]
Carneiro A +3 more
europepmc +1 more source
What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant? [PDF]
Kodjikian L +4 more
europepmc +1 more source
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. [PDF]
Pouwels XGLV +13 more
europepmc +1 more source
SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS. [PDF]
Kiernan DF.
europepmc +1 more source
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment. [PDF]
Rehak M +4 more
europepmc +1 more source
Intravitreal Fluocinolone Acetonide Implant and the Management of Non-infectious Posterior Uveitis [PDF]
openaire +1 more source
The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India. [PDF]
Biswas J +3 more
europepmc +1 more source
A New Approach for Diabetic Macular Edema Treatment: review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes. [PDF]
Estebainha R, Goldhardt R, Falcão M.
europepmc +1 more source

